According to Spherix Global Insights, data from over 1,000 psoriatic arthritis patients who recently switched therapies reveals that clinical factors, such as joint and skin efficacy, often drive the decision to switch, while non-clinical factors often influence the choice of the new brand. [30-May-2018] TNF Cycling in Psoriatic Arthritis Declines for th
May 30, 2018
· 4 min read